Using GLP-1s for Weight Loss and Maintenance After Bariatric Surgery

Emerging evidence positions GLP-1s as safe and effective therapeutic options to complement surgical outcomes and improve long-term weight management.

Published on Mar. 5, 2026

Got story updates? Submit your updates here. ›

Bariatric surgery has become a common treatment for severe obesity, but some patients experience insufficient weight loss or postoperative weight regain. While revisional surgery is an option, it carries higher risks. Emerging research suggests GLP-1 medications could be a safe and effective complement to bariatric procedures to improve long-term weight management, though standardized guidelines for their use are still lacking.

Why it matters

Bariatric surgery is a highly effective treatment for severe obesity, but a subset of patients struggle with inadequate weight loss or regain after the procedure. Finding safe and effective ways to improve long-term outcomes for these patients is crucial, as revisional surgeries carry higher risks.

The details

GLP-1 medications, which mimic a hormone that regulates blood sugar and appetite, have shown promise in helping patients maintain weight loss after bariatric surgery. However, there are currently no standardized guidelines for using GLP-1s in the post-bariatric population. Physicians must evaluate each patient's individual situation and tailor further lifestyle recommendations, medications, endoscopic procedures or surgeries accordingly.

  • The MedCentral article referenced in the source material was published on March 5, 2026.

The players

Inuk Zandvakili

A gastroenterologist and assistant professor of medicine at the University of Cincinnati College of Medicine.

Got photos? Submit your photos here. ›

What they’re saying

“Clinicians should first direct patients to re-engage their obesity medicine or bariatric surgery team as they may benefit from revisiting lifestyle and post-bariatric dietary recommendations.”

— Inuk Zandvakili, Gastroenterologist and Assistant Professor of Medicine (uc.edu)

“The options available to the patient depend on which initial bariatric surgery they received, however, [in the absence of evidence-based guidelines] the physician should evaluate the patient and tailor further lifestyle recommendations, medications, endoscopic procedures or surgeries to their individual situation.”

— Inuk Zandvakili, Gastroenterologist and Assistant Professor of Medicine (uc.edu)

What’s next

Researchers and clinicians are working to develop standardized guidelines for the use of GLP-1 medications in the post-bariatric surgery population to help improve long-term weight management outcomes.

The takeaway

While bariatric surgery is highly effective, a subset of patients struggle with inadequate weight loss or regain. Emerging evidence suggests GLP-1 medications could be a safe and effective complement to surgical interventions, but more research and clinical guidance is needed to optimize their use in this patient population.